Morquio A Registry Study MARS)
Research payments
$621,214
Through program year 2022, $621,214 in research payments was reported against Morquio A Registry Study MARS), across 189 payments, paid by BioMarin Pharmaceutical Inc..
- Paid by
- BioMarin Pharmaceutical Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $196,610 | 55 |
| 2021 | Research | $226,962 | 76 |
| 2020 | Research | $197,642 | 58 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Vikas Bhambhani Minneapolis, MN Named on 18 payments
- Can Ficicioglu Philadelphia, PA Named on 15 payments
- Shoji Yano Los Angeles, CA Named on 15 payments
- Michael Bober Wilmington, DE Named on 11 payments
- Tamanna Roshan Lal Baltimore, MD Named on 9 payments
- Damara Ortiz Pittsburgh, PA Named on 9 payments
- Amy Kritzer Boston, MA Named on 9 payments
- Priya Kishnani Durham, NC Named on 7 payments
- Darius Adams Morristown, NJ Named on 6 payments
- Barbara Burton Chicago, IL Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.